» Articles » PMID: 26850211

The Neurobiological Basis of Binge-eating Disorder

Overview
Date 2016 Feb 7
PMID 26850211
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Relatively little is known about the neuropathophysiology of binge-eating disorder (BED). Here, the evidence from neuroimaging, neurocognitive, genetics, and animal studies are reviewed to synthesize our current understanding of the pathophysiology of BED. Binge-eating disorder may be conceptualized as an impulsive/compulsive disorder, with altered reward sensitivity and food-related attentional biases. Neuroimaging studies suggest there are corticostriatal circuitry alterations in BED similar to those observed in substance abuse, including altered function of prefrontal, insular, and orbitofrontal cortices and the striatum. Human genetics and animal studies suggest that there are changes in neurotransmitter networks, including dopaminergic and opioidergic systems, associated with binge-eating behaviors. Overall, the current evidence suggests that BED may be related to maladaptation of the corticostriatal circuitry regulating motivation and impulse control similar to that found in other impulsive/compulsive disorders. Further studies are needed to understand the genetics of BED and how neurotransmitter activity and neurocircuitry function are altered in BED and how pharmacotherapies may influence these systems to reduce BED symptoms.

Citing Articles

Binge Eating Disorder and Metabolic Syndrome: Shared Mechanisms and Clinical Implications.

Alagha M, Al-Alam F, Saroufine K, Elias L, Klaimi M, Nabbout G Healthcare (Basel). 2025; 13(5).

PMID: 40077044 PMC: 11898466. DOI: 10.3390/healthcare13050482.


Exploring the utility of N-acetylcysteine for loss of control eating: protocol of an open-label single-arm pilot study.

Muthmainah M, Sketriene D, Anversa R, Harris E, Griffiths S, Gogos A Pilot Feasibility Stud. 2025; 11(1):19.

PMID: 39972374 PMC: 11837714. DOI: 10.1186/s40814-025-01598-5.


The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis.

Radkhah H, Rahimipour Anaraki S, Roudsari P, Bahri R, Zooravar D, Asgarian S Eat Weight Disord. 2025; 30(1):10.

PMID: 39891848 PMC: 11787217. DOI: 10.1007/s40519-025-01720-9.


A latent profile analysis of the functions of binge eating.

OLoghlen E, Galligan R, Grant S J Eat Disord. 2025; 13(1):13.

PMID: 39856757 PMC: 11761735. DOI: 10.1186/s40337-024-01147-0.


Relationships of eating behaviors with psychopathology, brain maturation and genetic risk for obesity in an adolescent cohort study.

Yu X, Zhang Z, Herle M, Banaschewski T, Barker G, Bokde A Nat Ment Health. 2025; 3(1):58-70.

PMID: 39811626 PMC: 11726452. DOI: 10.1038/s44220-024-00354-7.